Translational Development Acquisition Corp.(TDAC)

Shell Companies · New York City, NY

$10.84+0.02 (+0.14%)

Delayed quote: Oct 6, 2026, 2:27 PM EDT

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T18:58:54.558Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:58:54.558Z.

Quote observation: 2026-10-06T18:27:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 266,989,200
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 935c0e980908f1d3c2a070cdd724954857d1623c0e1dbdb6f9240be4a5331b99

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TDAC PS Ratio Metrics

PS RATIO

N/A

TDAC Competitors' PS Ratio

TDAC

Translational Development Acquisition Corp.

Current

Market Cap

$266.99M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TBCVU

Thunder Bridge Capital Partners V L

vs TDAC

Market Cap

$266.29M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KINS

Kingstone Companies, Inc.

vs TDAC

Market Cap

$269.42M

PS Ratio

1.21

TTM Avg

1.19

3Y Avg

0.94

5Y Avg

0.65

OACC

Oaktree Acquisition Corp. II

vs TDAC

Market Cap

$264.51M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PCAP

ProCap Acquisition Corp

vs TDAC

Market Cap

$264.47M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

vs TDAC

Market Cap

$264.38M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RWAY

Runway Growth Finance Corp.

vs TDAC

Market Cap

$269.65M

PS Ratio

4.31

TTM Avg

3.01

3Y Avg

3.94

5Y Avg

5.99

CGCF

Cartesian Growth Corp. Iv

vs TDAC

Market Cap

$270.05M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HWBK

Hawthorn Bancshares, Inc.

vs TDAC

Market Cap

$265.12M

PS Ratio

2.28

TTM Avg

2.18

3Y Avg

1.93

5Y Avg

1.90

SORN

Soren Acquisition Corp.

vs TDAC

Market Cap

$263.53M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Translational Development Acquisition Corp. (TDAC)	$266.99M	N/A	N/A	N/A	N/A
Thunder Bridge Capital Partners V L (TBCVU)vs ›	$266.29M	N/A	N/A	N/A	N/A
Kingstone Companies, Inc. (KINS)vs ›	$269.42M	1.21	1.19	0.94	0.65
Oaktree Acquisition Corp. II (OACC)vs ›	$264.51M	N/A	N/A	N/A	N/A
ProCap Acquisition Corp (PCAP)vs ›	$264.47M	N/A	N/A	N/A	N/A
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs ›	$264.38M	N/A	N/A	N/A	N/A
Runway Growth Finance Corp. (RWAY)vs ›	$269.65M	4.31	3.01	3.94	5.99
Cartesian Growth Corp. Iv (CGCF)vs ›	$270.05M	N/A	N/A	N/A	N/A
Hawthorn Bancshares, Inc. (HWBK)vs ›	$265.12M	2.28	2.18	1.93	1.90
Soren Acquisition Corp. (SORN)vs ›	$263.53M	N/A	N/A	N/A	N/A

How this was calculated

Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.

Revenue calculation and filing references
Fiscal period	Revenue	Source
Q3 FY2025Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20
Q4 FY2025Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-30
Q1 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15
Q2 FY2026Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14
TTM revenue	$0

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

TDAC PS Ratio Metrics

TDAC Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics